Rebecca Dai Nicole Garces Joanna Wong

Slides:



Advertisements
Similar presentations
Biopsychology of Psychiatric Disorders
Advertisements

Signs and Symptoms of Psychiatric Disorders LECTURE NO. 6.
Psychology and neuroscience Dr. Andrew Young Behavioural Neuroscience Group PS1009 Applied Psychology.
Schizophrenia Chapter 12. Schizophrenia Broad spectrum of cognitive and emotional dysfunctions that include –Hallucinations –Delusions –Disorganized speech.
Schizophrenia and Other Psychotic Disorders
Schizophrenia. Schizophrenia is a chronic, severe, disabling brain disease that interferes with a person’s ability to think clearly, to distinguish reality.
Catatonia Kristen Shirey, M.D. Duke University Hospital
Schizophrenia Lori Ridgeway PSYC What is Schizophrenia? Deterioration in fx Extreme disturbances in thoughts, perceptions, emotions, motor fx Affects.
RNFL Thickness. The ubiquitin proteasome pathway – PD genes Adapted from Eriksen et al Arch Neurol 2005, 6:
Psychotic Disorders. Archetype Schizophrenia Phenomenology The mental status exam The mental status exam Appearance Appearance Mood Mood Thought Thought.
Schizophrenia & Other Psychotic Disorders Fatima Alhaidar Professor of Psychiatry & Child and Adolescent Psychiatrist College of Medicine, KSU.
The ratios of the causes of catatonic features: Schizophrenic Mood disorders Neuroleptic-induced disorders GMC %
Schizophrenia and Schizoaffective Disorder DSM-IV-TR TM  Russell L. Smith, M.S., LPA, HSP-PA, CCBT, MAC, FABFCE, NCP American Psychiatric Association:
SCHIZOPHRENIA Literally means “Split or Broken Mind” The split is from Reality It is a severe form of psychopathology in which the person seems to disintegrate.
Schizophrenia  This term refers to the early idea that there is a split (schism) between affect (feelings) and cognition (thoughts)  Early physicians,
Catatonia Dr. Rajdeep Routh ST5 Old Age Psychiatry Leverndale Hospital, Glasgow Sept., 2012.
ORGANIC MENTAL DISORDERS Maria L.A. Tiamson, MD Asst. Professor, Psychiatry New York Medical College.
What Therapies Are Used to Treat Psychological Problems?
A framework for psychopathology
1 Catatonia James Robert Brašić, MD, MPH. 2 Acknowledgements This research is sponsored by The Essel Foundation, the National Alliance for Research on.
Slide 1 Neuroscience: Exploring the Brain, 3rd Ed, Bear, Connors, and Paradiso Copyright © 2007 Lippincott Williams & Wilkins Bear: Neuroscience: Exploring.
George F. Koob, Ph.D. Director
Anti-Anxiety Medications Brian Ladds, M.D.. Anti-Anxiety Medications 1903: first barbiturate introduced in U.S. –e.g., pentobarbital (Nembutal), amobarbital.
Schizophrenia Lunacy Madness Schizophrenia Delusions Downward drift theory.
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
2009/11/10 Morning Meeting Reporter R2 黃莉婷 Supervisor 鄧復旦 主任.
Author(s): Rachel Glick, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Schizophrenia Overview. Schizophrenia is the most severe and debilitating mental illness in psychiatry and is a brain disorder.
BRAIN IMAGING - PERSPECTIVES FOR STUDIES OF PSYCHIATRIC DISORDERS Jair C. Soares, M.D. Division of Mood and Anxiety Disorders, Dept of Psychiatry, University.
Elsevier items and derived items © 2005 by Mosby, Inc. Chapter 7 Psychotherapeutic Drug Therapy.
Schizophrenia & Other Psychotic Disorders
The term schizophrenia comes from two Greek words that mean splitting apart of mental functions. “Split mind“ U-Ajwbok&sns=em.
A cannabinoid hypothesis of Schizophrenia Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System.
ABERRANT FUNCTIONAL CONNECTIVITY OF DL PFC AND CINGULATE NETWORKS IN PATIENTS WITH MDD DURING WORKING MEMORY PROCESSING By Sharleen Yuan Special Topics-Affective.
Classification of Psychiatric Disorders
Psychotic Disorders Psychology. Presence of one or more of the following domains 1.delusions (grossly inaccurate beliefs) 2.hallucinations 3.Disorganized.
Biological Treatments of SZ Drugs – Atypical & Typical Learning Objectives.
The Placebo Response and Effect  Can be significant  30% or more in certain interventions  An individual’s overall disease manifestation and treatment.
CNS Depressants: Sedative- Hypnotics Chapter 6. Introduction to CNS Depressants Why are CNS depressants problematic? -Usually prescribed under physician’s.
Psychiatric Treatment
Chapter 22 Lesson 2 Schizophrenia gender identity disorder
Evaluation of the dopamine hypothesis (biological explanation)
Network interactions in schizophrenia — therapeutic implications
INTRODUCTION TO PSYCHIATRY
Aggressive Patient Assessment and Management
Prevalence and clinical characteristics of catatonia in persons with dementia admitted to an acute old age psychiatry ward  Dr Puja Sharma, Dr Ina Sawhney,
دكتر سيد غفور موسوي دانشيار روانپزشكي
A case of the Codeine phosphate abuser, since the seven years
The manifestation of psychiatric symptoms
Schizophrenia and Substance Use Disorders
The Biological Basis of Affective Disorders and Schizophrenia
Schizophrenia “split mind”
Starter Recap the three assumptions of the biological approach on your mini-whiteboard.
Sz: Types and diagnosis
Keith Slack Memorial ICL Training
Antipsychotics: The Essentials Module 4: Adverse Effects Neuroleptic Malignant Syndrome Flavio Guzmán, MD.
Module 23: Mood Disorders & Schizophrenia
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
CNS Depressants: Sedative-Hypnotics Chapter 6
Lithium: Mechanism of Action
James Robert Brašić, MD, MPH
The Bipolar Disorder Concept From Kraepelin to DSM-V
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
CNS Depressants: Sedative-Hypnotics Chapter 6
Topic Discussion By Alexandria Brown
The Biomedical Therapies
Describe and Evaluate Biological Treatments for Schizophrenia
Examples of the visual rating scale for the medial and lateral temporal lobe on MR coronal images displayed conventionally with the letter on the right.
(A) High intensity lesions in the left dorsolateral midbrain on T2 weighted magnetic resonance imaging in case 1. (A) High intensity lesions in the left.
Conceptual diagram of dopaminergic system and disease and drug effects
Presentation transcript:

Rebecca Dai Nicole Garces Joanna Wong Catatonia Rebecca Dai Nicole Garces Joanna Wong

Free template from www.brainybetty.com Outline History (Joanna) Diagnosis (Rebecca) Characteristics Subtypes Comorbidity Mechanisms (Nicole) Treatments (Joanna) How Catatonia is an ASC 9/19/2018 Free template from www.brainybetty.com

Definition of Catatonia Catatonia is a neuropsychiatric syndrome with a unique combination of mental, motor, vegetative and behavioral signs. 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com History Karl Ludwig Kahlbaum Coined the term ‘Catatonia’ “Catatonia is a brain disease with a cyclic, alternating course, in which the mental symptoms are, consecutively melancholy, mania, stupor, confusion, and eventually dementia.” 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Diagnosis Duck Principle – if it looks, walks, and quacks like a duck, then it’s a duck. Behavioral characteristics Mutism Stupor Negativism Posturing Echophenomena (Echolalia, Echopraxia) Stereotypy (palilalia) Ambitendency 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Subtypes Retarded Catatonia Excited Catatonia Periodic Catatonia Malignant Catatonia 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Comorbidity Mood disorders Psychosis Drug intoxication Drug withdrawal Epilepsy Developmental disorder 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Neurophysiology Neurochemical findings Dopaminergic system NMDA receptors Seratonin receptors GABA-A receptors 9/19/2018 Free template from www.brainybetty.com

GABA-A Receptors in Catatonic Patients Decreased binding in… Left sensorimotor cortex Right lateral orbitofrontal cortex Right posterior parietal cortex 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Mechanisms cont’d Affective symptoms Medial orbitofrontal deactivation Lateral orbitofrontal/prefrontal activation OPPOSITE of normals 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Mechanisms cont’d Motor symptoms Disturbed functional connectivity between orbitofrontal and premotor/motor cortex “top-down modulation” 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Mechanisms cont’d Behavioral symptoms Decreased activation in lateral orbitofrontal cortex Lesion study shows repetitive behaviors like that in catatonia 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Treatments Barbiturates W.J. Bleckwenn- First to report the relief of catatonia using barbiturates. Benzodiazepines are a common initial treatment i.e. Lorazepam, diazepam Lorazepam is more sustained 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Treatments (cont.) Electroconvulsive Treatment (ECT) Antipsychotic Drugs Taken with care because can cause neuroleptic malignant syndrome 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com Treatment (cont.) Sedatives Offered to excited catatonic patients with delirious mania Note: Also can can cause malignant catatonia with withdrawal 9/19/2018 Free template from www.brainybetty.com

Altered State of Consciousness Lack of control in many motor and affective behaviors Dysfunction between cortical and subcortical connection Limits awareness 9/19/2018 Free template from www.brainybetty.com

Free template from www.brainybetty.com References Carroll B: GABAa versus GABAb hypothesis of catatonia [letter]. Mov Disord 14: 702-703, 1999. Catatonia : from psychopathology to neurobiology / edited by Stanley N. Caroff … [et al.] Washington, DC : American Psychiatric Pub., c2004, 1st ed. Fink, Max and Michael Alan Taylor (2003). Catatonia: A Clinician’s Guide to Diagnosis and Treatment. Cambridge, Cambridge Univeristy Press. Northoff, Georg, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J. Neurol. Neurosurg. Psychiatry, 1999; 67; 445-450. Northoff, Georg, et al. Orbitofrontal Cortical Dysfunction n the Akinetic Catatonia: A Functional magnetic Resonance Imaging Study During Negative Emotional Stimulation. Schizophrenia Bulletin, 2004; 30; 2; 405-427. Northoff G: Catatonia—A Psychomotor Syndrome. Stuttgart, Enke Publisher, 1997. Northoff G: Brain imaging in catatonia: current findings and a pathophysiological model. CNS Spectr 5:34-46, 2000. Northoff G, Eckert J, Fritze J: Glutamatergic dysfunction in catatonia? Successful treatments of three acute akinetic catatonic patients with the NMDA-antagonist amantadine. J Neurol Neurosurg Psychiatry 62:404-406, 1997. Penland, Heath R, et al. The catatonic dilemma expanded. Annals of General Psychiatry, 2006; 5; 14; 1-9. Taylor, Michael, et al. Catatonia in Psychiatric Classification: A Home of Its Own. American Journal of Psychiatry, 2003; 160; 1233-1241. Stein, Elliot, et al. Selective Effects of the Endogenous Cannabinoid Arachidonylethanolamide (Anandamide) on Regional Cerebral Blood Flow in the Rat. Neuropsychopharmacology, 1998; 19; 6, 1-11. 9/19/2018 Free template from www.brainybetty.com